Tests a blood-cleaning cartridge with dialysis in people with kidney failure and inflammation
Tests a combined dialysis and sorbent cartridge treatment in adults on maintenance hemodialysis with inflammation.
Plain-language title generated from the registry record
Registry title: Studies on Adsorption International Learning Initiative Global
Key facts
- Where
- Moscow, RussiaSee the site
Where in Russia
- Botkin HospitalMoscow, RussiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Botkin Hospital
- Trial code
- NCT07123909
- Record updated
- 10 December 2025
- Original description
Use of sorption technologies in patients undergoing maintenance hemodialysis with inflammatory syndrome and clinical manifestations of uremiaRead full original descriptionShow less
The Use of Sorption Technologies in Patients Receiving Program Hemodialysis With Inflammatory Syndrome
Use of sorption technologies in patients undergoing maintenance hemodialysis with inflammatory syndrome and clinical manifestations of uremia
Inclusion: Adequate dialysis defined by a KT/V index ≥ 1.4; No active inflammatory process or infection; Age ≥ 18 years; Receiving standard hemodialysis regimen three times weekly, at least 4 hours per session; Participants with elevated interleukin-6 (IL-6) and/or C-reactive protein (CRP) levels exceeding local laboratory reference values.
Exclusion: Current use of steroids or immunosuppressive therapy; History of kidney transplantation; Diagnosis of cancer; Pregnancy.